Status
Conditions
Treatments
About
Prospective randomized (rhythm control or rate control) Objective of study
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Hemorrhagic transformation
Large cerebral lesion or cerebellar lesion (more than 1/3 of MCA area and 1/2 of ACA area, 1/2 of PCA area, 1/2 of cerebellar area)
active internal bleeding
Impossible to anticoagulation or anti arrhythmic drug
Valvular AF (MA> GII, Mechanical valve, Mitral valve replacement)
LV ejection fraction < 30%
Structural cardiac disease
Catheter ablation history for AF, Cardiac surgery
Already prescribed anti arrhythmic drugs
With severe medical disease
Expected survival < 1year
Severe alcoholics, drug addiction
Contraindication to MRI 15. Pregnancy
Primary purpose
Allocation
Interventional model
Masking
300 participants in 2 patient groups
Loading...
Central trial contact
Hui-Na Pak, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal